神经血管线圈栓塞补助设备的全球市场 - 市场规模(各市场区隔)，占有率，法规，偿付，治疗，预测(～2033年)

神经血管线圈栓塞辅助装置在线圈栓塞过程中使用，以帮助将线圈放置在动脉瘤内时将其固定到位。神经血管弹簧圈栓塞辅助装置包括弹簧圈栓塞辅助支架和弹簧圈栓塞辅助球囊。

神经血管弹簧圈栓塞辅助装置的使用因国家而异，取决于病例的复杂性、成本和医生的偏好。球囊的使用略高于支架，但这因国家而异。一些国家选择更便宜的气球。由于新技术和成本下降，球囊与支架的使用比例预计每年都会发生变化。

本报告提供全球神经血管线圈栓塞补助设备市场相关调查分析，提供主要企业市场占有率，主要趋势，创新的产品与技术，竞争情形等资讯。

市场模式的主要内容如下列。

已上市的神经血管线圈栓塞补助设备与不断变化的竞争格局

• 主要的产业趋势的考察
• 神经血管线圈栓塞补助设备市场区隔的年度收益与市场预测(2015年～2033年)
• 台数，平均销售价格，市场金额相关市场层级的资料

世界，地区，国家层级的市场固有的考察

• 各地区分类的全球趋势之特定市场定性资讯和国家/地区考虑因素
• 神经血管线圈栓塞补助设备市场SWOT分析
• 神经血管线圈栓塞补助设备市场竞争动态的考察和趋势

透过对医疗保健系统的真实、全面的了解来促进市场理解。市场进入部分还提供有关报销政策和监管环境的信息，使您能够更深入地研究市场动态。

• 各国医疗制度概要
• 各国偿付政策
• 各国医疗技术相关法规形势

对象企业

• Stryker Corp
• MicroVention Inc
• Cerenovus
• Medtronic Plc
• Balt SAS
• 其他

Neurovascular Coiling Assist Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Neurology Devices therapeutic area.

Neurovascular Coiling Assist Devices are used during coiling procedures to help hold coils in place as they are placed inside the aneurysm. Neurovascular Coiling Assist Devices can be coiling assist stents or coiling assist balloons.

Neurovascular coiling assist device usage varies between countries, depending on the complexity of the case, costs and doctor's preference. There is a slightly higher usage of balloons over stents, however, this varies depending on the country. Some countries may opt to use balloons due to the lower cost of the device. The usage split between balloons and stents are expected to change from year to year depending on new technology and lower costs.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Neurovascular Coiling Assist Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Neurovascular Coiling Assist Devices market revenue by segment and market outlooks from 2015-2033.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Neurovascular Coiling Assist Devices market.
• Competitive dynamics insights and trends provided for Neurovascular Coiling Assist Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Stryker Corp, MicroVention Inc, Cerenovus, Medtronic Plc, Balt SAS and Others

Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Neurovascular Coiling Assist Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Neurovascular Coiling Assist Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Neurovascular Coiling Assist Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Neurovascular Coiling Assist Devices market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.